Exhibit 10.1
SERIES C PREFERRED STOCK PURCHASE AGREEMENT
AMONG
THE
PRINCETON REVIEW, INC.,
BAIN
CAPITAL VENTURE FUND 2007, L.P.
PRIDES
CAPITAL FUND I LP
AND
THE
OTHER PURCHASERS NAMED ON SCHEDULE I HERETO
DATED
AS OF JULY 23, 2007
TABLE
OF CONTENTS
| |
|
|
|
|
|
|
|
1.
|
|
Authorization of Securities |
|
|
1 |
|
|
2.
|
|
Sale and Purchase of the
Series C Preferred Stock |
|
|
1 |
|
|
3.
|
|
Closing; Payment of Purchase Price;
Use of Proceeds |
|
|
2 |
|
|
3.1.
|
|
Closing |
|
|
2 |
|
|
3.2.
|
|
Use of Proceeds |
|
|
2 |
|
|
4.
|
|
Representations and Warranties of the
Purchasers; Register of Securities; Restrictions on Transfer |
|
|
2 |
|
|
4.1.
|
|
Organization |
|
|
2 |
|
|
4.2.
|
|
Validity |
|
|
2 |
|
|
4.3.
|
|
Brokers |
|
|
2 |
|
|
4.4.
|
|
Investment Representations and
Warranties |
|
|
3 |
|
|
4.5.
|
|
Acquisition for Own Account |
|
|
3 |
|
|
4.6.
|
|
Ability to Protect Its Own Interests
and Bear Economic Risks |
|
|
3 |
|
|
4.7.
|
|
Accredited Investor |
|
|
3 |
|
|
4.8.
|
|
Access to Information |
|
|
3 |
|
|
4.9.
|
|
Restricted Securities |
|
|
3 |
|
|
4.10.
|
|
Residence |
|
|
4 |
|
|
4.11.
|
|
Series B-1 Preferred Stock |
|
|
4 |
|
|
5.
|
|
Representations and Warranties by the
Company |
|
|
4 |
|
|
5.1.
|
|
Capitalization |
|
|
4 |
|
|
5.2.
|
|
Due Issuance and Authorization of
Capital Stock |
|
|
5 |
|
|
5.3.
|
|
Organization |
|
|
5 |
|
|
5.4.
|
|
Subsidiaries |
|
|
5 |
|
|
5.5.
|
|
Consents |
|
|
6 |
|
|
5.6.
|
|
Authorization; Enforcement |
|
|
6 |
|
|
5.7.
|
|
Issuance of Securities |
|
|
6 |
|
|
5.8.
|
|
No Conflicts |
|
|
7 |
|
|
5.9.
|
|
Material Contracts |
|
|
7 |
|
|
5.10.
|
|
Right of First Refusal; Stockholders
Agreement; Voting and Registration Rights |
|
|
8 |
|
|
5.11.
|
|
Previous Issuances |
|
|
8 |
|
|
5.12.
|
|
No Integrated Offering |
|
|
8 |
|
|
5.13.
|
|
SEC Reports; Financial
Statements |
|
|
8 |
|
|
5.14.
|
|
No Undisclosed Material
Liabilities |
|
|
9 |
|
|
5.15.
|
|
Litigation |
|
|
10 |
|
|
5.16.
|
|
Taxes |
|
|
10 |
|
|
5.17.
|
|
Employee Matters |
|
|
10 |
|
|
5.18.
|
|
Compliance with Laws |
|
|
11 |
|
|
5.19.
|
|
Brokers |
|
|
11 |
|
|
5.20.
|
|
Environmental Matters |
|
|
11 |
|
|
5.21.
|
|
Intellectual Property Matters |
|
|
12 |
|
| |
|
|
|
|
|
|
|
5.22.
|
|
Related-Party Transactions |
|
|
15 |
|
|
5.23.
|
|
Title to Property and Assets |
|
|
16 |
|
|
5.24.
|
|
Disclosure |
|
|
16 |
|
|
5.25.
|
|
Absence of Changes |
|
|
16 |
|
|
5.26.
|
|
Illegal Payments |
|
|
18 |
|
|
5.27.
|
|
Suppliers and Customers |
|
|
18 |
|
|
5.28.
|
|
Regulatory Permits |
|
|
19 |
|
|
5.29.
|
|
Insurance |
|
|
19 |
|
|
5.30.
|
|
[Reserved] |
|
|
19 |
|
|
5.31.
|
|
Investment Company |
|
|
19 |
|
|
5.32.
|
|
Listing and Maintenance
Requirements |
|
|
19 |
|
|
5.33.
|
|
Accountants |
|
|
19 |
|
|
5.34.
|
|
Solvency |
|
|
20 |
|
|
5.35.
|
|
Application of Takeover
Protections |
|
|
20 |
|
|
5.36.
|
|
Stock Options |
|
|
20 |
|
|
6.
|
|
Conditions of Parties’
Obligations |
|
|
21 |
|
|
6.1.
|
|
Conditions of the Purchasers’
Obligations |
|
|
21 |
|
|
6.2.
|
|
Conditions of the Company’s
Obligations |
|
|
23 |
|
|
6.3.
|
|
Conditions of Each Party’s
Obligations |
|
|
24 |
|
|
7.
|
|
Covenants. |
|
|
24 |
|
|
7.1.
|
|
Reporting Requirements; Access to
Records |
|
|
24 |
|
|
7.2.
|
|
Integration |
|
|
24 |
|
|
7.3.
|
|
Securities Laws Disclosure;
Publicity |
|
|
25 |
|
|
7.4.
|
|
Reservation of Common Stock |
|
|
25 |
|
|
7.5.
|
|
Listing of Common Stock |
|
|
25 |
|
|
7.6.
|
|
Filings |
|
|
25 |
|
|
7.7.
|
|
Board Representation |
|
|
26 |
|
|
7.8.
|
|
Board Committees |
|
|
26 |
|
|
7.9.
|
|
Board Observer Rights |
|
|
26 |
|
|
7.10.
|
|
Nomination Process |
|
|
26 |
|
|
7.11.
|
|
Standstill Agreements |
|
|
26 |
|
|
8.
|
|
Transfer Restrictions; Restrictive
Legend |
|
|
27 |
|
|
8.1.
|
|
Transfer Restrictions |
|
|
27 |
|
|
8.2.
|
|
Unlegended Certificates |
|
|
27 |
|
|
9.
|
|
Registration, Transfer and
Substitution of Certificates for Securities |
|
|
28 |
|
|
9.1.
|
|
Stock Register; Ownership of
Securities |
|
|
28 |
|
|
9.2.
|
|
Replacement of Certificates |
|
|
28 |
|
|
10.
|
|
Definitions |
|
|
28 |
|
|
11.
|
|
Enforcement |
|
|
31 |
|
|
11.1.
|
|
Cumulative Remedies |
|
|
31 |
|
|
11.2.
|
|
No Implied Waiver |
|
|
32 |
|
|
12.
|
|
Confidentiality |
|
|
32 |
|
|
13.
|
|
Miscellaneous |
|
|
32 |
|
|
13.1.
|
|
Waivers and Amendments |
|
|
32 |
|
-iii-
| |
|
|
|
|
|
|
|
13.2.
|
|
Notices |
|
|
33 |
|
|
13.3.
|
|
Indemnification |
|
|
34 |
|
|
13.4.
|
|
No Waivers |
|
|
35 |
|
|
13.5.
|
|
Successors and Assigns |
|
|
35 |
|
|
13.6.
|
|
Headings |
|
|
35 |
|
|
13.7.
|
|
Governing Law |
|
|
35 |
|
|
13.8.
|
|
Independent Nature of
Purchasers’ Obligations and Rights |
|
|
35 |
|
|
13.9.
|
|
Fees and Expenses |
|
|
36 |
|
|
13.10.
|
|
Jurisdiction |
|
|
37 |
|
|
13.11.
|
|
Waiver of Jury Trial |
|
|
37 |
|
|
13.12.
|
|
Counterparts; Effectiveness |
|
|
37 |
|
|
13.13.
|
|
Entire Agreement |
|
|
37 |
|
|
13.14.
|
|
Severability |
|
|
38 |
|
LIST OF
EXHIBITS
| |
|
|
|
EXHIBIT A
|
|
Certificate of Designation |
|
EXHIBIT B
|
|
Certificate of Elimination |
|
EXHIBIT C
|
|
Form of Investor Rights
Agreement |
|
EXHIBIT D
|
|
Form of Termination and Release
Agreement |
-iv-
SERIES C PREFERRED STOCK PURCHASE AGREEMENT
This
SERIES C PREFERRED STOCK PURCHASE AGREEMENT (this “
Agreement ”) is made and entered into this 23rd
day of July, 2007 (the “ Purchase Date ”)
by and among The Princeton Review, Inc., a Delaware corporation
(the “ Company ”), Bain Capital Venture
Fund 2007, L.P., a Delaware limited partnership (“ Bain
Capital ”), Prides Capital Fund I LP, a Delaware
limited partnership (“ Prides Capital ”)
and the other entities and individuals as listed on
Schedule I attached hereto (Bain Capital, Prides
Capital and such other entities and individuals, the “
Purchasers ”). Certain terms used and not
otherwise defined in the text of this Agreement are defined in
Section 10 hereof.
WITNESSETH
WHEREAS,
the Company desires to issue and to sell to the Purchasers, and the
Purchasers desire to purchase from the Company, the shares of
Series C Preferred Stock set forth on the Schedule I
attached hereto in the column Shares Purchased, all in accordance
with the terms and provisions of this Agreement;
NOW,
THEREFORE, in consideration of the foregoing and the mutual
representations, warranties and covenants herein contained, the
parties hereto, intending to be bound, hereby agree as
follows:
1. Authorization of
Securities . The Company has authorized the issuance and sale
of up to 60,000 shares of its Series C Convertible Preferred
Stock, par value $0.01 per share (“ Series C Preferred
Stock ”), which will be convertible into shares of
the Company’s common stock, par value $0.01 per share (the
“ Common Stock ”), and which will have
the rights, preferences and privileges set forth in the form of
Certificate of Designation attached hereto as Exhibit A
(the “ Certificate of Designation ”). The
shares of Common Stock into which the Series C Preferred Stock
is convertible are sometimes referred to herein as the “
Conversion Shares ” and the shares of Series C
Preferred Stock and the Conversion Shares are sometimes referred to
herein collectively as the “ Securities
”.
2. Sale and Purchase of the
Series C Preferred Stock. Upon the terms and subject to
the conditions herein contained, the Company agrees to sell to each
Purchaser, and each Purchaser agrees, severally and not jointly, to
purchase from the Company, at the Closing, the number of shares of
Series C Preferred Stock set forth in the column “Shares
Purchased” opposite such Purchaser’s name on
Schedule I attached hereto, for a purchase price per
share equal to $1,000 (the “ Purchase Price
”), which shall be paid in cash or a combination of cash,
shares of the Company’s Series B-1 Cumulative
Convertible Preferred Stock (the “ Series B-1
Preferred Stock ”), which shares shall be cancelled
and retired pursuant to the certificate attached hereto as
Exhibit B and the cancellation and termination of the
Fletcher Rights (as such term is defined in the Agreement between
the Company and Fletcher International, Ltd. and its
-1-
successors and assigns, dated as of May 28, 2004), as set
forth in the column “Consideration” opposite such
Purchaser’s name on Schedule I attached
hereto.
3. Closing; Payment of
Purchase Price; Use of Proceeds .
3.1.
Closing . The closing (the “ Closing
”) with respect to the transaction contemplated in
Section 2 hereof shall take place at the offices of Ropes
& Gray LLP, One International Place, Boston, Massachusetts at
10:00 a.m. on July 23, 2007, or at such other time and
place as the Company and Purchasers may agree (the “
Closing Date ”). At the Closing, the Company
shall deliver to each Purchaser a certificate representing the
Series C Preferred Stock which such Purchaser is purchasing at
the Closing as set forth on Schedule I attached hereto,
registered in the name of such Purchaser, against delivery to the
Company by such Purchaser of a wire transfer or delivery of shares
and rights (as the case may be) in the amount of the Purchase Price
therefor.
3.2.
Use of Proceeds . The Company shall use the proceeds from
the sale of Series C Preferred Stock hereunder for general
corporate purposes, to pay Company indebtedness and to repurchase
all of the outstanding Series B-1 Preferred Stock and the
cancellation and termination of the Fletcher Rights.
4. Representations and
Warranties of the Purchasers; Register of Securities; Restrictions
on Transfer . Each Purchaser (except in the case of
Section 4.11, which shall apply only to the Purchaser named
therein), severally as to itself and not jointly, represents and
warrants to the Company as follows:
4.1.
Organization . The Purchaser which is duly formed or
organized, validly existing and in good standing under the laws of
its jurisdiction of organization or formation, and has all
requisite corporate, limited liability company, partnership or
trust (as the case may be) power and authority to enter into this
Agreement and the other Transaction Documents and instruments
referred to herein to which it is a party and to consummate the
transactions contemplated hereby and thereby.
4.2.
Validity . The execution, delivery and performance of this
Agreement and the other Transaction Documents and instruments
referred to herein, in each case to which such Purchaser is a
party, and the consummation by such Purchaser of the transactions
contemplated hereby and thereby, have been duly authorized by all
necessary action on the part of such Purchaser. This Agreement has
been duly executed and delivered by such Purchaser, and the other
Transaction Documents and instruments referred to herein to which
it is a party will be duly executed and delivered by such
Purchaser, and each such agreement constitutes or will constitute a
valid and binding obligation of such Purchaser enforceable against
it in accordance with its terms.
4.3.
Brokers . There is no broker, investment banker, financial
advisor, finder or other person which has been retained by or is
authorized to act on behalf of such Purchaser
-2-
who
might be entitled to any fee or commission for which the Company
will be liable in connection with the execution of this Agreement
and the consummation of the transactions contemplated hereby.
4.4.
Investment Representations and Warranties . Such Purchaser
understands that the offering and sale of the Securities have not
been registered under the Securities Act and are being made in
reliance upon federal and state exemptions for transactions not
involving a public offering which depend upon, among other things,
the bona fide nature of the investment intent and the accuracy of
Purchaser’s representations as expressed herein. The
Purchaser acknowledges that, except as set forth in the Investor
Rights Agreement, the Company has no obligation to register or
qualify the Securities for resale.
4.5.
Acquisition for Own Account . Such Purchaser is acquiring
the Securities for its own account for investment and not with a
view toward distribution in a manner which would violate the
Securities Act.
4.6.
Ability to Protect Its Own Interests and Bear Economic Risks
. Such Purchaser, by reason of the business and financial
experience of its management, has the capacity to protect its own
interests in connection with the transactions contemplated by this
Agreement and the other Transaction Documents. Such Purchaser is
able to bear the economic risk of an investment in the Securities
and is able to sustain a loss of all of its investment in the
Securities without economic hardship if such a loss should
occur.
4.7.
Accredited Investor . Such Purchaser is an “accredited
investor” as that term is defined in Regulation D
promulgated under the Securities Act.
4.8.
Access to Information . Such Purchaser has been given access
to all Company documents, records, and other information, and has
had adequate opportunity to ask questions of, and receive answers
from, the Company’s officers, employees, agents, accountants,
and representatives concerning the Company’s business,
operations, financial condition, assets, liabilities, and all other
matters relevant to its investment in the Securities. The
representations of Purchasers contained in this Section 4.8
shall not affect the ability of the Purchasers to rely on the
representations and warranties made by the Company pursuant to
Section 5 of this Agreement.
4.9.
Restricted Securities .
(a)
Such Purchaser understands that the Securities will be
characterized as “restricted securities” under the
federal securities laws inasmuch as they are being acquired from
the Company in a transaction not involving a public offering and
that under such laws and applicable regulations such Securities may
be resold without registration under the Securities Act only in
certain limited circumstances.
-3-
(b)
Such Purchaser acknowledges that the Securities must be held
indefinitely unless subsequently registered under the Securities
Act and under applicable state securities laws or an exemption from
such registration is available.
(c)
Such Purchaser is aware of the provisions of Rule 144 under
the Securities Act which permit limited resale of securities
purchased in a private placement.
4.10.
Residence . The office or offices of such Purchaser in which
its investment decision was made, and which is its principal place
of business, in the case of a corporation, limited liability
company, partnership or other entity, or is its residence, in the
case of an individual, is located at the address or addresses of
such Purchaser set forth on Schedule I hereto.
4.11.
Series B-1 Preferred Stock . Prides Capital is the
beneficial owner of the shares of B-1 Preferred Stock as set forth
in the column “Consideration” opposite such
Purchaser’s name on Schedule I attached hereto,
and has good and valid title to such shares. Upon the Closing,
Prides Capital will have no rights in connection with such shares
other than its rights pursuant to this Agreement and the
Transaction Documents.
5. Representations and
Warranties by the Company . Except as disclosed by the Company
in a written Disclosure Schedule provided by the Company to the
Purchasers dated the date hereof (the “ Disclosure
Schedule ”), the Company represents and warrants to
each Purchaser that the statements contained in this Section 5
are complete and accurate as of the date of this Agreement. The
Disclosure Schedule shall be arranged in sections corresponding to
the numbered and lettered sections and subsections contained in
this Section 5, and the disclosures in any section or
subsection of the Disclosure Schedule shall qualify other sections
and subsections in this Section 5 only to the extent it is readily
apparent from a reasonable reading of the disclosure that such
disclosure is applicable to such other sections and
subsections.
5.1.
Capitalization .
(a) As
of the date hereof, and after giving effect to the filing of the
Certificate of Designation and the Closing, the authorized capital
stock of the Company consists of 100,000,000 shares of Common
Stock, par value $0.01 per share, and 5,000,000 shares of preferred
stock, par value $0.01 per share, of which 60,000 shares are
designated Series C Preferred Stock. As of the date hereof,
and after giving effect to the filing of the Certificate of
Designation and the Closing, there are 28,252,216 outstanding
shares of Common Stock, 60,000 shares of Series C Preferred
Stock outstanding, 2,957,457 shares of Common Stock are available
for issuance upon the exercise of outstanding stock options,
warrants, or other convertible rights and 1,308,843 shares of
Common Stock are reserved for issuance under the Company’s
2000 Stock Incentive Plan (the “ Benefit Plan
”). As of the date hereof, and after giving effect to the
filing of the Certificate of Designation and the Closing, the
Company has no other shares of capital stock authorized, issued or
outstanding. Except for the shares of Series B-1 Preferred
Stock held by Prides Capital as set forth in the column
“Consideration”
-4-
opposite such
Purchaser’s name on Schedule I attached hereto,
there are no other shares of Series B-1 Preferred Stock
outstanding. A capitalization table presenting the capitalization
of the Company after giving effect to the filing of the Certificate
of Designation and the Closing is set forth on Schedule
5.1(a) hereto.
(b)
As of the date hereof, except as set forth on the SEC Reports or on
Schedule 5.1(b) and except as may be granted or required by
this Agreement or the other Transaction Documents, (i) there
are no outstanding options, warrants, scrip, rights to subscribe
to, calls or commitments of any character whatsoever relating to,
or securities or rights convertible into or exercisable or
exchangeable for, any shares of capital stock of the Company, or
arrangements by which the Company is or may become bound to issue
additional shares of capital stock, nor are any such issuances or
arrangements contemplated; (ii) there are no agreements or
arrangements under which the Company is or may become obligated to
register the sale of any of its securities under the Securities
Act; (iii) the Company has no obligation (contingent or
otherwise) to purchase, redeem or otherwise acquire any of its
equity securities or any interests therein or to pay any dividend
or make any distribution in respect thereof; and (iv) the
Company has not reserved any shares of capital stock for issuance
pursuant to any stock option plan or similar arrangement.
5.2.
Due Issuance and Authorization of Capital Stock . All of the
outstanding shares of capital stock of the Company have been
validly issued and are fully paid and non-assessable. The sale and
delivery of the shares of Series C Preferred Stock to the
Purchasers, when issued, sold and delivered in accordance with the
terms and for the consideration hereof, and the issuance of the
Conversion Shares upon conversion of the shares of Series C
Preferred Stock will vest in the holders thereof legal and valid
title to such Securities, free and clear of any lien, claim,
judgment, charge, mortgage, security interest, pledge, escrow,
equity or other encumbrance (collectively, “
Encumbrances ”).
5.3.
Organization . The Company and each of its Subsidiaries
(a) is duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of
its formation, except, in the case of its Subsidiaries, where the
failure to be so incorporated or organized would not have a
Material Adverse Effect, (b) is duly qualified to do business
as a foreign entity and is in good standing in each jurisdiction
where the nature of the property owned or leased by it or the
nature of the business conducted by it makes such qualification
necessary, except where the failure to be so qualified would not
have a Material Adverse Effect, and (c) has all requisite
corporate power and authority to own or lease and operate its
assets and carry on its business as presently being conducted. The
Company has its principal place of business and chief executive
office in New York, New York.
5.4.
Subsidiaries . All of the direct and indirect Subsidiaries
of the Company are set forth on Schedule 5.4 . The
Company owns, directly or indirectly, all of the capital stock or
other equity interests of each Subsidiary free and clear of any
Encumbrances, and all of the
-5-
issued
and outstanding shares of capital stock of each Subsidiary are
validly issued and are fully paid, non-assessable and free of
preemptive and similar rights to subscribe for or purchase
securities.
5.5.
Consents . Assuming the accuracy of the representations made
by the Purchasers in Section 4 of this Agreement and
except as set forth on Schedule 5.5 , neither the
execution, delivery or performance of the Certificate of
Designation, this Agreement or the other Transaction Documents by
the Company, nor the consummation by it of the obligations and
transactions contemplated hereby or thereby (including, without
limitation, the issuance, the reservation for issuance and the
delivery of the Series C Preferred Stock or the issuance and
delivery of the Conversion Shares) requires any consent of,
authorization by, exemption from, filing with or notice to any
Governmental Entity or any other Person, other than (a) the
filing of the Certificate of Designation with the Secretary of
State of the State of Delaware, (b) the filings required to
comply with the Company’s registration obligations under the
Investor Rights Agreement and (c) filings required under
applicable U.S. federal and state securities laws.
5.6.
Authorization; Enforcement . The Company has all requisite
corporate power and has taken all necessary corporate action
required for the due authorization, execution, delivery and
performance by the Company of this Agreement and the other
Transaction Documents and the consummation of the transactions
contemplated hereby and thereby (including, without limitation, the
issuance of the Securities and the provision to the Purchasers of
the rights contemplated by the Transaction Documents) and no action
on the part of the stockholders of the Company is required. The
execution, delivery and performance by the Company of each of the
Transaction Documents, the execution and filing of the Certificate
of Designation, and the consummation by the Company of the
transactions contemplated hereby and thereby, have been duly
authorized by all necessary corporate action on the part of the
Company. This Agreement has been duly executed and delivered by the
Company, and the other Transaction Documents and instruments
referred to herein to which it is a party will be duly executed and
delivered by the Company, and each such agreement constitutes or
will constitute a valid and binding obligation of the Company
enforceable against it in accordance with its terms, subject to
bankruptcy, insolvency, fraudulent conveyance or other similar laws
affecting creditors’ rights generally and to general
equitable principles.
5.7.
Issuance of Securities . The Securities, when issued, sold
and delivered in accordance with the terms and for the
consideration set forth in this Agreement, will be duly authorized
and a sufficient number of shares of authorized but unissued shares
of Common Stock have been reserved for issuance upon conversion of
the Series C Preferred Stock, and upon such issuance or
conversion in accordance with the terms of this Agreement or the
Certificate of Designation, as the case may be, all such Securities
will be duly authorized, validly issued, fully paid and
non-assessable, and free from all taxes and Encumbrances and will
not be subject to preemptive rights or other similar rights of
stockholders of the Company, and the issuance of such shares will
not impose personal liability upon the holder thereof.
-6-
5.8.
No Conflicts . Except as set forth on
Schedule 5.8 , the execution, delivery and performance
of each of the Transaction Documents, the execution and filing of
the Certificate of Designation, and the consummation of the
transactions contemplated hereby and thereby (including, without
limitation, the issuance and reservation for issuance, as
applicable, of the Series C Preferred Shares and the
Conversion Shares) will not (a) result in a violation of the
amended and restated certificate of incorporation and by-laws of
the Company (the “ Charter Documents ”)
or the certificates of formation, operating agreements,
certificates of incorporation or by-laws of its Subsidiaries,
(b) conflict with or result in the breach of the terms,
conditions or provisions of or constitute a default (or an event
which with notice or lapse of time or both would become a default)
under, or give rise to any right of termination, acceleration or
cancellation under, any agreement, lease, mortgage, license,
indenture, instrument or other contract to which the Company or any
Subsidiary is a party, (c) result in a material violation of
any law, rule, regulation, order, judgment or decree (including,
without limitation, U.S. federal and state securities laws and
regulations) applicable to the Company or any Subsidiary or by
which any property or asset of the Company or any Subsidiary is
bound or affected, (d) result in a material violation of any
rule or regulation of the NASD or its Trading Markets, or
(e) result in the creation of any Encumbrance upon any of the
Company’s or any Subsidiary’s assets, except, in the
case of clauses (b) or (e), for any such conflicts,
violations, breaches, defaults or other occurrences that would not
have, individually or in the aggregate, a Material Adverse Effect.
The Company is not in material violation of its Charter Documents
and neither the Company nor any Subsidiary is in material default
(and no event has occurred which, with notice or lapse of time or
both, would cause the Company to be in material default) under, nor
has there occurred any event giving others (with notice or lapse of
time or both) any rights of termination, amendment, acceleration or
cancellation of, any Material Contract. The business of the Company
and its Subsidiaries is not being conducted in violation in any
material respect of any law, ordinance or regulation of any
Governmental Entity except for such violations that would not have
a Material Adverse Effect.
5.9.
Material Contracts . Each Material Contract of the Company
is listed on Schedule 5.9 hereof. Each Material
Contract is the legal, valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms,
except to the extent that enforceability may be limited by
bankruptcy, insolvency, fraudulent conveyance or other similar laws
affecting creditors’ rights generally and by general
equitable principles. There has not occurred any breach, violation
or default or any event that, with the lapse of time, the giving of
notice or the election of any Person, or any combination thereof,
would constitute a breach, violation or default by the Company
under any such Material Contract or, to the knowledge of the
Company, by any other Person to any such contract, except for such
violations or defaults that would not have a Material Adverse
Effect. To the knowledge of the Company, it has not been notified
that any party to any Material Contract intends to cancel,
terminate, not renew or exercise an option under any Material
Contract, whether in connection with the transactions contemplated
hereby or otherwise.
-7-
5.10.
Right of First Refusal; Stockholders Agreement; Voting and
Registration Rights . Except pursuant to any agreement listed
as an exhibit to an SEC Report, this Agreement or the other
Transaction Documents, no party has any right of first refusal,
right of first offer, right of co-sale, preemptive right or other
similar right regarding the securities of the Company. Except
pursuant to any agreement listed as an exhibit to an SEC Report or
Schedule 5.10 , there are no provisions of the Charter
Documents, no Material Contracts other than the Certificate of
Designation, this Agreement or the other Transaction Documents,
which (a) may affect or restrict the voting rights of the
Purchasers with respect to the Securities in their capacity as
stockholders of the Company, (b) restrict the ability of the
Purchasers, or any successor thereto or assignee or transferee
thereof, to transfer the Securities, (c) would adversely
affect the Company’s or any Purchaser’s right or
ability to consummate the transactions contemplated by this
Agreement or comply with the terms of the other Transaction
Documents or the Certificate of Designation and the transactions
contemplated hereby or thereby, (d) require the vote of more
than a majority of the Company’s issued and outstanding
Common Stock, voting together as a single class, to take or prevent
any corporate action, other than those matters requiring a
different vote under Delaware law, or (e) entitle any party to
nominate or elect any director of the Company or require any of the
Company’s stockholders to vote for any such nominee or other
person as a director of the Company in each case above.
5.11.
Previous Issuances . Except as disclosed on
Schedule 5.11 , all shares of capital stock and other
securities issued by the Company prior to the Closing Date have
been issued in transactions registered under or exempt from the
registration requirements under the Securities Act and all
applicable state securities or “blue sky” laws, and in
compliance with all applicable corporate laws. The Company has not
violated the Securities Act or any applicable state securities or
“blue sky” laws in connection with the issuance of any
shares of capital stock or other securities prior to the Closing
Date.
5.12.
No Integrated Offering . Neither the Company, nor any of its
Affiliates or any other Person acting on the Company’s
behalf, has directly or indirectly engaged in any form of general
solicitation or general advertising with respect to the Securities
nor have any of such Persons made any offers or sales of any
security of the Company or its Affiliates or solicited any offers
to buy any security of the Company or its Affiliates under
circumstances that would require registration of the Securities
under the Securities Act or cause this offering of Securities to be
integrated with any prior offering of securities of the Company for
purposes of the Securities Act or any applicable shareholder
approval provisions of any Trading Market on which any of the
securities of the Company are listed or designated.
5.13.
SEC Reports; Financial Statements .
(a)
Except as disclosed on the SEC Reports or Schedule 5.13
, the Company has filed all reports, schedules, forms, statements
and other documents required to be filed by the Company under the
Securities Act and the Exchange Act, including pursuant to Section
13(a) or 15(d) thereof, for the two years preceding the date
hereof
-8-
(the foregoing
materials, including the exhibits thereto and documents
incorporated by reference therein, being collectively referred to
herein as the “ SEC Reports ”) on a
timely basis or has received a valid extension of such time of
filing and has filed any such SEC Reports prior to the expiration
of any such extension. As of their respective dates, the SEC
Reports complied in all material respects with the requirements of
the Securities Act and the Exchange Act, as applicable, and none of
the SEC Reports, when filed, contained any untrue statement of a
material fact or omitted to state a material fact required to be
stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were
made, not misleading. All Material Contracts to which the Company
is a party or to which the property or assets of the Company are
subject are required to be included as part of or specifically
identified in the SEC Reports are so included or specifically
identified. Except as disclosed to the Purchasers in writing, the
Company has filed all SEC Reports required to be filed with the SEC
since December 31, 2004 (the “ Post-2004 SEC
Reports ”); provided that, if the Company amends any of
its Post-2004 SEC Reports, such amendment shall not mean or imply
that any representation or warranty in this Agreement was not true
and correct when made or became untrue thereafter.
(b) The
financial statements of the Company included in the SEC Reports
comply in all material respects with applicable accounting
requirements and the rules and regulations of the Commission with
respect thereto as in effect at the time of filing. Such financial
statements have been prepared in accordance with GAAP, except as
may be otherwise specified in such financial statements or the
notes thereto and except that unaudited financial statements may
not contain all footnotes required by GAAP, and fairly present in
all material respects the financial position of the Company and its
consolidated subsidiaries as of and for the dates thereof and the
results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal,
immaterial, year-end audit adjustments.
5.14.
No Undisclosed Material Liabilities . As of the date of this
Agreement, there are no liabilities of the Company, of any kind
whatsoever, whether interest-bearing indebtedness, or liabilities
accrued, contingent, absolute, determined, determinable or
otherwise, other than liabilities:
(a)
reflected in the financial statements included in the SEC
Reports;
(b)
disclosed on Schedule 5.14 hereto;
(c)
incurred in the ordinary course of business, consistent with past
practice;
(d)
created under, or incurred in connection with, this Agreement, the
other Transaction Documents or the Certificate of Designation;
or
-9-
(e)
which would not in the aggregate be material to the Company.
5.15.
Litigation . There is no action, suit, investigation or
other proceeding pending against, or to the knowledge of the
Company, threatened against or affecting, the Company or any of its
Subsidiaries or any of their properties or to the knowledge of the
Company any of its or their officers or directors before any court
or arbitrator or any Governmental Entity that could cause a
Material Adverse Effect, except as disclosed in the SEC Reports or
as set forth on Schedule 5.15 . To the knowledge of the
Company, there are no facts that would cause a reasonable person to
believe that such a proceeding would likely result.
5.16.
Taxes . The Company and each of its Subsidiaries has
properly filed all federal, foreign, state, local, and other tax
returns and reports which are required to be filed, which returns
and reports were properly completed and are true and correct in all
respects, and all taxes, interest, and penalties due and owing have
been timely paid, except for those taxes, interest or penalties
which would not have a Material Adverse Effect. There are no
outstanding waivers or extensions of time with respect to the
period for assessing or auditing any tax or tax return of the
Company or any Subsidiary, or claims now pending or matters under
discussion between the Company or any Subsidiary and any taxing
authority in respect of any tax of the Company or any
Subsidiary.
5.17.
Employee Matters .
(a) The
Company has listed any “employee benefit plan” subject
to the Employee Retirement Income Security Act of 1974, as amended
(“ ERISA ”), that it maintains for
employees on any agreement listed as an exhibit to an SEC Report or
Schedule 5.17(a) .
(b)
Except as set forth on Schedule 5.17(b) , (i) no
director or officer or other employee of the Company will become
entitled to any retirement, severance or similar benefit or
enhanced or accelerated benefit (including any acceleration of
vesting) or lapse of repurchase rights or obligations with respect
to any employee benefit plan subject to ERISA or other benefit
under any compensation plan or arrangement of the Company (each, an
“ Employee Benefit Plan ”)) solely as a
result of the transactions contemplated in this Agreement; and
(ii) no payment made or to be made to any current or former
employee or director of the Company, or any of its Affiliates by
reason of the transactions contemplated hereby (whether alone or in
connection with any other event, including, but not limited to, a
termination of employment) will constitute an “excess
parachute payment” within the meaning of Section 280G of
the Code.
(c) No
executive officer, to the knowledge of the Company, is, or is now
expected to be, in violation of any term of any employment
contract, confidentiality, disclosure or proprietary information
agreement or non-competition agreement, or any other contract or
agreement or any restrictive covenant, and, to the knowledge of the
Company, the continued employment of each such executive officer
does not subject the
-10-
Company or any
of its Subsidiaries to any liability with respect to any of the
foregoing matters, except for such violations which would not have
a Material Adverse Effect.
(d) The
Company and its Subsidiaries are in compliance with all applicable
federal, state, local and foreign statutes, laws (including,
without limitation, common law), judicial decisions, regulations,
ordinances, rules, judgments, orders and codes respecting
employment, employment practices, labor, terms and conditions of
employment and wages and hours, and no work stoppage or labor
strike against the Company or any Subsidiary is pending or, to
their knowledge, threatened, nor is the Company or any Subsidiary
involved in or, to their knowledge, threatened with any labor
dispute, grievance or litigation relating to labor matters
involving any employees of the Company or any Subsidiary, except
for any of the foregoing which would not have a Material Adverse
Effect. To the Company’s knowledge, there are no suits,
actions, disputes, claims (other than routine claims for benefits),
investigations or audits pending or, to the knowledge of the
Company, threatened in connection with any Employee Benefit
Plan.
5.18.
Compliance with Laws . The Company and its Subsidiaries
have, and are in compliance with the terms of, all franchises,
permits, licenses and other rights and privileges necessary to
conduct the Company’s present and proposed business and are
in compliance with and have not violated, in any respect, any
applicable provisions of any laws, statutes, ordinances or
regulations or the terms of any judgments, orders, decrees,
injunctions or writs, except for any of the foregoing which would
not have a Material Adverse Effect..
5.19.
Brokers . Except as disclosed on Schedule 5.19 ,
there is no investment banker, broker, finder, financial advisor or
other person which has been retained by or is authorized to act on
behalf of the Company who is entitled to any fee or commission in
connection with the transactions contemplated by this
Agreement.
5.20.
Environmental Matters .
(a)
(i) No written notice, notification, demand, request for
information, citation, summons, complaint or order has been
received by, and no investigation, action, claim, suit, proceeding
or review is pending or, to the knowledge of the Company,
threatened by any Person against the Company or any of its
Subsidiaries and no penalty has been assessed against the Company
or any of its Subsidiaries, in each case, with respect to any
matters relating to or arising out of any Environmental Law;
(ii) the Company and its Subsidiaries are in material
compliance with all applicable Environmental Laws; and
(iii) to the knowledge of the Company, there are no material
liabilities of or relating to the Company and its Subsidiaries
relating to or arising out of any Environmental Law, and there is
no existing condition, situation or set of circumstances which
could reasonably be expected to result in a such a liability.
-11-
(b) For
purposes of this Agreement, the term “ Environmental
Laws ” means federal, state, local and foreign
statutes, laws, binding judicial decisions, regulations,
ordinances, rules, binding judgments, binding orders, codes,
binding injunctions and permits relating to human health and the
environment, including, but not limited to, Hazardous Materials;
and the term “ Hazardous Material ” means
all substances or materials regulated as hazardous, toxic,
explosive, dangerous, flammable or radioactive under any
Environmental Law including, but not limited to:
(i) petroleum, asbestos, or polychlorinated biphenyls and
(ii) in the United States, all substances defined as Hazardous
Substances, Oils, Pollutants or Contaminants in the National Oil
and Hazardous Substances Pollution Contingency Plan.
5.21.
Intellectual Property Matters .
(a)
“ Intellectual Property ” means any and
all of the following arising under the laws of the United States,
any other jurisdiction or any treaty regime: (i) all
inventions (whether patentable or unpatentable and whether or not
reduced to practice), all improvements thereon, and all patents,
patent applications and patent disclosures and all reissuances,
continuations, continuations-in-part, divisionals, revisions,
extensions and reexaminations thereof, (ii) all trademarks,
service marks, trade dress, logos, trade names and corporate names
and all translations, adaptations, derivations and combinations
thereof and including all goodwill associated therewith, and all
applications, registrations and renewals in connection therewith,
(iii) all copyrightable works, mask works or moral rights, all
copyrights and all applications, registrations and renewals in
connection therewith, (iv) all trade secrets and confidential
business information (including, without limitation, ideas,
research and development, know-how, formulas, compositions,
manufacturing and production processes and techniques, technical
data, designs, drawings, specifications, customer and supplier
lists, pricing and cost information and business and marketing
plans and proposals), (v) all computer software (including,
without limitation, data and related documentation and except for
any commercial “shrink-wrapped” software) and source
codes, (vi) all other proprietary rights, (vii) all
copies and tangible embodiments of the foregoing (in whatever form
or medium) and (viii) all licenses or agreements in connection
with the foregoing. “ Company Intellectual
Property ” means all Intellectual Property which is
used in connection with, and is material to, the business of the
Company and its Subsidiaries and all Intellectual Property owned by
the Company and its Subsidiaries, provided that any Intellectual
Property that is licensed by the Company or any of its Subsidiaries
shall be included within the meaning of Company Intellectual
Property only within the scope of use by the Company and its
Subsidiaries or in connection with the Company’s
business.
(b)
Except as set forth on Schedule 5.21(b) , with respect
to each item of Company Intellectual Property:
-12-
(1) the Company or its Subsidiary
possesses all rights, titles and interests in and to the item if
owned by the Company or its Subsidiary, free and clear of any
Encumbrance, license or other restriction, and possesses all rights
necessary in the case of a licensed item to use such item in the
manner in which it presently uses the item or reasonably
contemplates using such item, and the Company has taken or caused
to be taken reasonable and prudent steps to protect its rights in
and to, and the validity and enforceability of, the item owned by
the Company or its Subsidiary;
(2) the item, if owned by the Company
or its Subsidiary, is not, and if licensed, to the knowledge of the
Company is not, subject to any outstanding injunction, judgment,
order, decree, ruling or charge naming the Company or a
Subsidiary;
(3) no action, suit, proceeding,
hearing, investigation, charge, complaint, claim or demand is
pending or, to the knowledge of the Company, has been or is being
threatened which challenges the legality, validity, enforceability,
use or ownership of the item;
(4) to the knowledge of the Company,
the Company or its Subsidiary has sufficient right, title and
interest to use or own the item without infringement upon any
Intellectual Property Right or other right of any third party,
except for such failure which would not have a Material Adverse
Effect;
(5) except in the ordinary course of
business and to the knowledge of the Company, the Company and its
Subsidiaries have not agreed to indemnify any person for or against
any interference, infringement, misappropriation or other conflict
with respect to the item;
(6) neither the Company nor any
Subsidiary is bound by or a party to any option, license,
sublicense, agreement or permission of any kind with respect to the
item;
(7) to the knowledge of the Company,
no third party has interfered with, infringed upon, misappropriated
or otherwise come into conflict with the Company Intellectual
Property, except for such interference, infringement or
misappropriation which would not have a Material Adverse
Effect;
(8) neither the Company nor any
Subsidiary is party to any option, license, sublicense or agreement
or permission of any kind covering the item that it is in breach or
default thereunder, and no event has occurred which, with notice or
lapse of time, would constitute a breach or default or permit
termination, modification or acceleration thereunder, except for
such breach or default which would not have a Material Adverse
Effect; and
-13-
(9) to the knowledge of the Company,
each option, license, sublicense, agreement or permission of any
kind covering the item is legal, valid, binding, enforceable
against the Company or its Subsidiary, as the case may be, and in
full force and effect.
All applications for, pending or
registered patents, copyrights, trademarks, and service marks in
the United States and any other jurisdiction (x) if owned by
the Company or a Subsidiary, and (y) if licensed, to the
knowledge of the Company, are valid and subsisting and in full
force and effect or are currently pending and are not subject to
any claims, Encumbrances, taxes or other fees except for periodic
filing and maintenance fees. Except as set forth on
Schedule 5.21(b) and except for such infringement or
misappropriation which would not have a Material Adverse Effect,
the Company and its Subsidiaries have not, to the knowledge of the
Company, infringed upon, misappropriated or otherwise come into
conflict with any Intellectual Property rights of third parties,
and there is no pending or, to the knowledge of the Company,
threatened claim or litigation against the Company or any
Subsidiary contesting the right to use any third party’s
Intellectual Property rights, asserting the misuse of any thereof,
or asserting the infringement or other violation thereof.
(c) All
domain names owned by the Company or its Subsidiaries and material
to the business of the Company and its Subsidiaries (the “
Domain Names ”) have been and are duly
registered with Network Solutions, Inc. (“ NSI
”) through NSI’s registration procedures, and are
operating, accessible domain names. The Company or a Subsidiary
owns and, to the best of the Company’s knowledge, has not
waived, forfeited or granted to any third parties, any rights,
title or interest in or to the Domain Names including, without
limitation, any benefits, entitlements or rights of renewal with
respect to the Domain Names. NSI has not notified the Company or
any Subsidiary that any of the Domain Names have been placed on
“hold” or are otherwise subject to a dispute or
potential dispute pursuant to NSI’s dispute resolution
policy.
(d) To
the knowledge of the Company, none of the key employees of the
Company or any Subsidiary are obligated under any contract
(including, without limitation, licenses, covenants, or commitments
of any nature) or other agreement, or subject to any judgment,
decree, or order of any court or administrative agency, that would
interfere with the use of his or her reasonable diligence to
promote the interests of the Company or that would conflict with
the Company’s businesses as presently conducted. Neither the
execution, delivery or performance of this Agreement, nor the
carrying on of the Company’s businesses by the employees of
the Company and its Subsidiaries, nor the conduct of the
Company’s businesses as presently conducted, will conflict
with or result in a breach of the terms, conditions or provisions
of, or constitute a default under, any contract, covenant, or
instrument under which any such key employee is obligated, and
which conflict, breach or default would have a Material Adverse
Effect.
-14-
|